Navigate
X
    QualityStocks
  • 18 years ago

VIVUS, Inc. (NASDAQ: VVUS)

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company, is focused on developing and commercializing next-generation therapeutic products designed to target obesity and sexual health. The potential market for obesity ranges from $5 billion to $10 billion annually according to speculating analysts, while the potential market for an effective diabetes therapy that causes weight loss is in excess of $2 billion. The indications targeted by VIVUS’ sexual health products each represent a potential market of more than $1 billion per annum. For further information, visit the Company’s web site at www.vivus.com.

Tags Rodman & Renshaw
Related Post
  1. Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

    In the United States alone, close to one million people are living with MS, with…

  2. Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step

    California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…

  3. Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership

    The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…